申请人:ARPIDA AS
公开号:WO2005092872A1
公开(公告)日:2005-10-06
Benzothiazine compounds of the general formula (I) and pharmaceutically acceptable salts or esters thereof are peptide deformylase inhibitors useful in the treatment or prevention of infections and other diseases in which peptide deformylases are involved, especially in the treatment of bacterial and parasitic infections, for example infections fully or partly caused by microorganisms belonging to Staphylococcus, Enterococcus, Streptococcus, Haemophilus, Moraxella, Escherichia, Mycobacterium, Mycoplasma, Pseudomonas, Chlamydia, Rickettsia, Klebsiella, Shigella, Salmonella, Bordetella, Clostridium, Helicobacter, Campylobacter, Legionella or Neisseria.
通用公式(I)的苯并噻嗪化合物及其药学上可接受的盐或酯是肽变形酶抑制剂,在治疗或预防涉及肽变形酶的感染和其他疾病方面很有用,特别是在治疗细菌和寄生虫感染方面,例如完全或部分由属于葡萄球菌,肠球菌,链球菌,流感嗜血杆菌,摩拉氏菌,大肠杆菌,分枝杆菌,支原体,假单胞菌,沙雷菌,克拉米杆菌,立克次体,克雷伯氏菌,志贺氏菌,沙门氏菌,百日咳杆菌,梭菌,幽门螺杆菌,空肠弯曲菌,军团菌或莫拉克斯菌等微生物引起的感染的治疗中。